Yangrong Tang for Fatigue in Cancer Survivors: A Phase I/II Open-Label Study

This open-label, prospective, phase I/II trial was performed to establish the safety and efficacy of Traditional Chinese Medicine (TCM) herbal products for treating non–anemia-related fatigue in patients with cancer.